Objectives-The purpose of this study was to evaluate the imaging features of clear cell hidradenoma on ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI).
C lear cell hidradenoma is a relatively rare tumor of sweat gland origin. Although traditionally regarded as showing eccrine differentiation, it is now accepted that these tumors can show either eccrine or apocrine differentiation. 1, 2 It has been called various names, including eccrine acrospiroma, solid-cystic hidradenoma, nodular hidradenoma, and clear cell acrospiroma, as its originating cell line has been investigated. 3 It is most often solitary and normally grows slowly, with sizes commonly documented to be in the range of 5 to 30 mm. It most frequently occurs in the fourth to eighth decades of life and affects women twice as often as men. It is most commonly seen in the trunk, lower limbs, and head. 4 These small but palpable superficial lesions rarely require radiologic evaluation and are most often diagnosed and treated by excision. There are few reports on the findings of clear cell hidradenoma on ultrasonography (US), [5] [6] [7] [8] [9] [10] [11] [12] computed tomography (CT), 13 and magnetic resonance imaging (MRI). 9, [14] [15] [16] [17] [18] [19] [20] The purpose of this retrospective study was to analyze and describe the imaging features of clear cell hidradenoma seen on US, CT, and MRI.
Materials and Methods

Patients and Clinical Data
This study was performed in accordance with the Declaration of Helsinki. This human study was approved by Institutional Review Board of the Ulsan University Hospital. Adult participant consent was not required because the need for obtaining informed consent was waived. We retrospectively searched the pathologic databases of 2 different medical institutions using the search terms "clear cell hidradenoma," "eccrine acrospiroma," and "nodular hidradenoma" for the period from January 1, 2004 , to December 31, 2016. Thirty-seven cases were identified. Twenty-eight patients in whom a preoperative US, CT, or MRI examination was not performed were excluded, leaving 9 patients for inclusion in this study. Patient demographics, clinical records, and radiologic reports were reviewed.
Imaging
Ultrasonographic examinations were performed with multifrequency linear array transducers (5-12 or 7-15 MHz) and either an HDI 5000 or iU22 US system (Philips Healthcare, Bothell, WA). All US examinations included grayscale images obtained in the transverse and longitudinal planes as well as color Doppler images. Computed tomographic images were acquired with a Sensation 16 or Somatom Definition Flash system (Siemens Medical Systems, Erlangen, Germany) or a Brilliance iCT system (Philips Healthcare, Amsterdam, the Netherlands). Axial source images were obtained, along with reformatted coronal and sagittal images. Images were typically acquired before and after intravenous administration of iopromide (100-120 mL; Ultravist, 300 mgI/mL; Bayer Schering Pharma, Berlin, Germany) at a rate of 3 mL/s. Magnetic resonance images were acquired on a 3.0-T MRI unit (Achieva; Philips Healthcare, Amsterdam, the Netherlands). The MRI tumor protocol parameters consisted of the following sequences: T1-weighted images, T2-weighted images, fatsuppressed T2-weighted images, and fat-suppressed T1-weighted postcontrast images. An intravenous bolus injection of gadoterate meglumine (0.1 mmol/kg of body weight; Dotarem; Guerbet, Paris, France) was administered at a rate of 2 mL/s for postcontrast examination.
Imaging Analysis
Two musculoskeletal radiologists (J.Y.L. and B.S.K.) with 2 and 14 years of clinical experience, respectively, retrospectively reviewed all of the US, CT, and MRI features on a digital workstation by consensus. The analysis of the US features focused on the layer in which each tumor was located (epidermis, dermis, or subcutaneous fat layer), size (longest diameter in 3 dimensions), shape (round, oval, or lobular), margin (well-defined or poorly defined), echo texture (homogeneous or heterogeneous), echogenicity relative to adjacent muscle (hyperechoic, isoechoic, hypoechoic, anechoic, or combined), posterior acoustic enhancement, internal calcification, and septum. The presence of vascularity was determined, and its pattern (ie, peripheral, central, or both peripheral and central) was identified on color Doppler images.
The CT features of the lesions were characterized according to their location, size, shape, and margin, as described for the US features. We also assessed the presence of calcification and enhancement pattern (homogeneous or heterogeneous).
The features of the lesions seen on MRI were characterized according to their location, size, shape, and margin, as described for the US features. Moreover, the signal intensity on T1-and T2-weighted MR images was described as low, equal, high, or combined, and as either homogeneous or heterogeneous. The enhancement pattern was described as homogeneous or heterogeneous.
Results
The demographic data and morphologic features of clear cell hidradenoma are summarized in Table 1 . The study population (mean age, 48.9 years; range, 28-70 years) included 5 female patients and 4 male patients. Of these, 5 patients underwent only US; 2 patients underwent only CT; 1 patient underwent both US and CT; and 1 patient underwent both US and MRI. Three lesions were located in the neck, 2 in the axilla, 2 in a lower extremity (ie, knee [n 5 1] and foot [n 5 1]), 1 in the upper arm, and 1 in the scalp. The overlying skin was intact in all patients. All lesions appeared as painless palpable masses and were slow growing, as observed over 6 months, according to the medical records. Five lesions were located only in the subcutaneous fat layer, and 4 were located in both the subcutaneous fat layer and the dermis ( Figures 1A, 2A , and 3A). The sizes ranged from 5 to 30 mm in greatest diameter, with a mean diameter of 18.4 mm. Five lesions were smaller than 20 mm in diameter. The lesions were lobular shaped in 6 cases and oval in 3 cases. All of the tumors had well-defined margins.
The imaging features of clear cell hidradenoma are summarized in Table 2 . The echo texture was heterogeneous in 6 of the 7 lesions imaged by US and homogeneous in the remaining lesion. There was a combination of an anechoic portion and an inner echogenic portion in 6 cases and only hypoechogenicity in 1 case. Two tumors had multiple septa in the anechoic portion of the mass. All of the tumors showed posterior acoustic enhancement. No tumor had internal echogenic foci indicating calcification. All lesions showed blood flow in the mass, which was both central and peripheral in 5 cases and peripheral only in 2 cases ( Figure 1B ). All 3 masses imaged by CT showed low attenuation and heterogeneous enhancement of the peripheral wall and internal nodule ( Figure 2B ). Furthermore, there was enhancement of multiple septa in 1 mass, which was also imaged by US. Calcification was not seen in any of the masses.
On MRI, the cystic component showed low signal intensity on T1-weighted images and high signal intensity on T2-weighted images ( Figure 3B ). The central nodule showed low signal intensity on T1-and T2-weighted images. The mass showed heterogeneous enhancement of the peripheral wall, septa, and central nodule after intravenous administration of gadolinium ( Figure 3C ).
On microscopic examinations, all masses showed the features characteristic of clear cell hidradenoma. There was a cystic structure as a whole, mixed with a solid portion protruding from the cyst wall ( Figure 2C ). The solid portions were composed of both polygonal to short spindle cells with a clear cytoplasm and small cells with a slightly eosinophilic cytoplasm ( Figure 3D) .
None of the 9 tumors was correctly diagnosed preoperatively by US, CT, or MRI. The most common misdiagnoses were an epidermal inclusion cyst and hemangioma. No malignant features were evident in the resected specimens, and there was no recurrence in any patient over an average of 6.4 years (range, 1-20 years).
Discussion
Clear cell hidradenoma is classified as a cutaneous tumor originating from skin appendages. However, all of the clear cell hidradenomas in our study were primarily located in the subcutaneous fat layer with or without involvement of the dermal layer and were similar to those in previously published reports. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] This finding could be attributed to the relatively strong and elastic nature of the dermal layer compared with that of the subcutaneous fat layer, as was another sweat gland tumor reported by Jin et al. 21 Furthermore, there was no extension of the lesion to the epidermis or muscular structures in any case.
Although the largest reported diameter of a clear cell hidradenoma was 9.5 cm, 22 most of these tumors measured only a few centimeters. The mean tumor diameter of 18.4 mm in our study was comparable with that in other studies. Furthermore, most of the tumors had a lobular shape, and all had well-defined margins. These findings were also concordant with those in previous reports. Six of the 7 lesions imaged by US in this study had a heterogeneous appearance in the mass. This heterogeneous appearance was attributable to an inner echogenic portion with background anechoic portions. When we correlated the US features with the histologic findings, the background anechoic portions corresponded to the cystic component, and the inner echogenic portions corresponded to the solid component. Homogeneous hypoechogenicity was found in only 1 patient, whose tumor had the smallest size and was only examined with a large-field-of-view transducer, so it was possible that 
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we could not differentiate the inner echoic portion from the anechoic background in this case.
Two of our patients had tumors that showed multiple septa in the anechoic portion. Although that appearance was reported by Wortsman et al, 5 a detailed explanation had not been described. We speculate that the presence of multiple septa may relate to the chronicity of clear cell hidradenoma and be explained by the hemorrhagic contents of the cystic components. Complications such as bleeding and inflammatory changes may be present in cystic soft tissue tumors; therefore, they may have a more heterogeneous appearance and show thickening of the outer lining or internal septa. 23 In our study, we found that all clear cell hidradenomas showed posterior acoustic enhancement, as described in 3 previous case reports. 5, 8, 12 Posterior acoustic enhancement or increased through-transmission occurs because of the relatively lower attenuation of the sound beam in the imaged lesion compared with the adjacent soft tissues, which results in a hyperechoic appearance of soft tissues deep within the lesion. 24 Therefore, this phenomenon occurs in clear cell hidradenoma because of its cystic component.
Although Ghai and Bukhanov 12 reported calcification in the cyst wall and mural nodules on US, most of the previous case reports stated that calcification was not shown. In our study, calcification was not seen on US or on the histologic examination in any case.
Both central blood flow and peripheral blood flow have been described in 6 patients, and central blood flow only has also been described in 4 patients with clear cell hidradenoma in previous case reports. 5, 8, 9, 11, 12 In our study, blood flow was found in all cases on color Doppler examinations and was present in both the central echogenic portion and the peripheral wall in most cases. Vascularity was attributable to the presence of multiple vascular channels, which was confirmed on the pathologic examinations.
All 3 of our cases imaged by CT showed heterogeneous enhancement of the peripheral wall and internal nodule, similar to a previous report. 13 True cystic lesions, such as ganglion and synovial cysts, may show a thin rim of enhancement in the cyst wall but no internal enhancement. In contrast, soft tissue tumors with fluid contents related to hemorrhage or necrosis show enhancement of their solid-tumor components after administration of a contrast agent. 25 Although Lee et al. 13 described calcification in the wall of the mass on CT, it was not seen in any case with CT images in our study.
On MRI, clear cell hidradenoma showed low signal intensity on T1-weighted images and heterogeneous high signal intensity on T2-weighted images, as well as an enhancing solid component on contrastenhanced T1-weighted images. These findings were concordant with those in most of the previously reported cases. However, hemorrhage and sweat gland excretions in the cystic portion may cause variable signal intensity of the fluid contents of the tumor, as described by Mullaney et al. 9 Clear cell hidradenomas are often found to be encapsulated and well circumscribed on histopathologic examinations and are lobulated masses with cystic spaces. The solid portion contains 2 types of cells: ie, cells at the periphery that are fusiform with an elongated nucleus and basophilic cytoplasm and cells in the center that are polygonal with a round nucleus and clear cytoplasm. These polygonal cells contain abundant glycogen, which is washed away during fixation and embedding, leading to the empty appearance of these cells, which gives them their name: ie, clear cell. 12 Malignant transformation of clear cell hidradenoma, although rare, is well documented. 26, 27 Malignancy can arise de novo or develop secondarily in a preexisting benign hidradenoma. 27 It can be difficult to differentiate between benign and malignant tumors both clinically and microscopically. Malignant clear cell hidradenomas, or hidradenocarcinomas, tend to metastasize through lymphatic and vascular pathways and have a poor prognosis. 12 In our study, no patient had local recurrence or distant metastasis of clear cell hidradenoma.
The differential diagnosis of clear cell hidradenoma includes an epidermal inclusion cyst, a vascular malformation, a ganglionic cyst, a peripheral nerve sheath tumor, synovial sarcoma, and basal cell carcinoma. An epidermal inclusion cyst is usually a well-circumscribed mildly echogenic oval mass with occasional linear anechoic and/or echogenic reflections, increased throughtransmission, a hypoechoic rim, and no Doppler flow. 28 On MRI, an intermediate-to high-T2 signal mass with occasional low signal debris and no central enhancement can strengthen the diagnosis of an epidermal inclusion cyst. 28 A vascular malformation shows prominent vascular channels on grayscale US, hypervascularity on color Doppler US, and phleboliths with posterior acoustic shadowing within the mass. 29 A vascular malformation tends to be isointense or hypointense to muscle on T1-weighted MR images and to show a high signal on T2-weighted MR images. Furthermore, serpentine vascular flow voids are sometimes evident on both sequences, and there is strong enhancement with intravenous gadolinium. 29 A ganglionic cyst is typically a cystic lesion with floating echoes or internal septa and does not show vascular flow on Doppler examinations. 29 On MRI, ganglionic cysts are typically smooth, well-circumscribed, thin- walled, unilocular, and homogeneously T2-hyperintense lesions. An identifiable thin stalk communicating with the joint space is not infrequent. 30 Peripheral nerve sheath tumors are often hypoechoic with posterior acoustic enhancement. The presence of intrinsic blood flow on color Doppler US and peripheral nerve continuity suggest a peripheral nerve sheath tumor. 31 The signal intensity of peripheral nerve sheath tumors is nonspecific, with isointensity or slight hyperintensity to muscle on T1-weighted images and hyperintensity on T2-weighted images, as well as a variable enhancement pattern and foci of heterogeneity. 29 Synovial sarcoma usually presents as a focal nodular round or lobulated solid but hypoechoic soft tissue mass on US. 32 Its features on MRI include multilobulation and marked heterogeneity (creating the "triple sign") with hemorrhage, fluid levels, and septa. 32 Basal cell carcinoma appears as hypoechoic or heterogeneous lesions with irregular borders and may show characteristic hyperechoic spots on US. 33 Basal cell carcinoma is isoattenuating or hypoattenuating relative to the adjacent musculature on CT images and appears as a T1-isointense or -hyperintense and T2-hyperintense lesion relative to muscle on MR images. 33 We recognize several limitations to this study. First, we included only a small number of patients. Second, the study was retrospective in nature. Finally, interpretations of the surgical specimens were performed by multiple pathologists at 2 different medical institutions.
In conclusion, clear cell hidradenoma is usually located in the subcutaneous fat layer, has a well-defined margin, appears as a cystic mass with an internal solid nodule, and occasionally has multiple septa on US, CT, and MRI.
